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INTRODUCTION:  Tendo  achilles  (TA)  ruptures  are  commonly  encountered  in  orthopaedic  practice.  These
can  be managed  operatively  or conservatively  depending  on  various  factors  like  patient  age,  activity
levels,  co  morbidities,  patient  expectations  and  surgeon  preference.  They  are  usually  treated  in plaster
cast  immobilisation  if managed  conservatively.eywords:
endo achilles ruptures
eep  vein thrombosis (DVT)
ulmonary embolism (PE)
CASE REPORT:  We  present  a  case  of fatal  pulmonary  embolism  following  conservatively  managed  Tendo
achilles  (TA) rupture  in  a  young  man  treated  as  an  orthopaedic  outpatient.
DISCUSSION: There  are  no  current  clear  guidelines  on  venous  thromboembolism  (VTE)  prophylaxis  in
conservatively  managed  outpatients  with  cast  immobilisation.
CONCLUSION: Our  case  report  highlights  the  importance  of  recognition  of this  aspect  of patient  manage-
rent  
gical ment  and  reviews  the  cur
© 2011 Sur
. Introduction
TA ruptures are commonly encountered in clinical practice in
rthopaedics. These can be managed both operatively and non
peratively depending on various factors. When managed non ope-
atively, patients are treated in plaster casts as outpatients. DVT
rophylaxis in these patients is debatable and currently there no
lear national guidelines in the management of such patients.
.  Presentation of case
A 34 year old healthy young adult male of British origin (height
79 cm and weight 75 kg, BMI  23.4) presented to accident and
mergency with inability to weight bear while playing football. He
eard a snap and felt as though somebody had shot him at the
ack of the ankle without any direct tackle. He was a plumber by
ccupation and football was his hobby. He had no risk factors like
revious history of deep venous thrombosis (DVT), family history
f clotting disorders, intake of medications, smoking or prior pro-
lems with his ankle. Clinical examination revealed a palpable gap
n the musculotendinous junction and compression of the calf did
ot cause plantar ﬂexion of the ankle suggesting complete rupture
f TA.
Options available for management were discussed with him
nd he preferred non operative treatment. He was  given above
nee cast with foot in equinus for two weeks and then planned
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for below knee plaster with foot in equinus for two  weeks followed
by below knee cast with foot in neutral for two  weeks at which
stage plan was  to let him start partial weight bearing for another
four weeks.
He  presented ten days following injury to fracture clinic with
a sensation of the plaster feeling tight. He was examined by the
orthopaedic consultant on call and his calf was  soft, non tender
and there was no increase in girth to suggest DVT. He felt a lot
better once the plaster was removed. Decision was taken to change
to a below knee cast at this stage even though it was  four days
earlier than planned. He was  comfortable with the new below knee
plaster and was given an appointment in two  weeks time for the
next change.
However, he represented to the fracture clinic four days
later complaining of some breathlessness since the previous
night. Examination revealed no clinical signs of DVT in the
calf or pulmonary embolism (PE) like tachypnoea or redu-
ced saturation on air. He was getting some chest pain on
and off since few days and he felt that it was  secondary
to him using axillary crutches causing pectoral muscle strain.
In view of his symptoms, blood tests including D dimers,
Chest radiograph, clotting/antibody proﬁle, electrocardiogram
(ECG) were organised and he was admitted under the physi-
cians.
His clotting proﬁle, ECG and chest radiograph were
normal. Blood investigations did not reveal any antinu-
clear/antiphospholipid antibodies. D dimers were found to be
raised signiﬁcantly and the calf doppler revealed a popliteal vein
Open access under CC BY-NC-ND license. thrombus. He was  treated empirically for PE with therapeutic dose
of subcutaneous anticoagulant immediately and CT angiogram
was organised for the next day. Later that night, he had cardio-
pulmonary arrest and resuscitation attempts failed. Post-mortem
NC-ND license. 
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evealed a massive pulmonary embolus at the bifurcation of the
ulmonary vessels.
.  Discussion
The annual incidence of venous thromboembolism (VTE) is
pproximately 0.1% with that of DVT being 1–2%.1–3 The quoted
ncidence of VTE following a leg injury immobilised can vary from
.1% to 40%. Proximal vein thrombosis (symptomatic or asympto-
atic) is reported to carry a risk of 50% PE.4 The risk of DVT has been
eported as being similar for both soft tissue injuries and fractures.5
ne case of fatal PE following ankle fracture has been reported in
he English literature.6 Age, major operations such as lower limb
rthroplasty/pelvic operations, previous history of venous throm-
osis, protein C/S deﬁciencies, or Factor V Leiden mutation, are
uoted as predisposing risk factors.7 VTE events generally present
ithin the ﬁrst four weeks of immobilisation3 in outpatients with
njury of the lower limb although DVT has been reported within
4 h of application of the cast.8
Kock et al.8 found that the incidence of DVT was much higher
reaching statistical signiﬁcance) in the no treatment group com-
ared to prophylaxis group in their prospective randomised single
entre control trial of 239 patients. Kujath et al.3 also found similar
esults in their RCT of 253 patients.
In the prospective randomised doubleblind placebo controlled
ulticentre trial by Lassen et al.9 of 371 patients, the incidence
f DVT was higher in the placebo group which was statistically
igniﬁcant.
In contrast, Jorgensen et al.10 found no statistically signiﬁcant
ifference between the treatment and control groups in the multi-
entre RCT of 205 patients comparing tinzaparin with no treatment.
here was no placebo control in their study and it had a high dro-
out rate which could have affected the results.
Cochrane review11 of six RCT’s including the previous men-
ioned papers3,8,9,10 with a total of 1490 patients comparing DVT
rophylaxis with low molecular weight heparin (LMWH) with
o treatment in outpatients concluded that LMWH  signiﬁcantly
educes VTE when immobilisation of the lower leg.
This  review noted potential bias which could have affected the
esults in these RCT’s. These studies excluded high risk patients and
he drop out rate in them was on the higher side. The method of
iagnosing DVT varied between ultrasonography and venography.
he dosage of LMWH  was  different in each study and there was
eterogeneity with respect to type of injury and surgical interven-
ion.
One study12 found low incidence of DVT and no cases of PE in
onservatively treated ankle fractures and did not recommended
outine VTE prophylaxis. Current American College of Chest Phy-
icians (ACCP)13 and Scottish Intercollegiate Guidelines Network
SIGN)14 guidelines recommend that all patients undergoing elec-
ive hip or knee replacement should be routinely considered for
MWH prophylaxis for seven to ﬁfteen days after operation and
ontinued for four to ﬁve weeks in high-risk patients. This is not
he same for patients with immobilisation in lower limb cast and
he decision is left to the individual clinicians even though the
ncidence of symptomatic DVT is similar to elective lower limb
rthroplasty.5 This is possibly due to the need for prolonged course
f anticoagulation which would imply regular outpatient supervi-
ion.
Prophylaxis using warfarin has been shown to be effective in
educing the mortality from pulmonary embolism.15 Alternative
ptions like aspirin have been found to be not as efﬁcacious as
ow molecular weight heparin therapy.12 Direct thrombin inhibitor
abigatran etexilate and the Factor Xa inhibitor rivaroxaban have
een found to be as effective as LMWH  in randomised trials for elec-
ive lower limb arthroplasty.5 Further studies are needed to provePEN  ACCESS
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their  efﬁcacy in DVT prevention in lower limbs immobilised with
plaster.
In our department, all outpatients undergoing following lower
limb immoblisation are assessed for risk of DVT and are treated
with LMWH  if indicated for the duration.
In a survey of current practice in the United Kingdom of
thromboproplylaxis following cast immobilisation for lower limb
injuries,16 there was  substantial variation and inconsistency in
practice among orthopaedic departments in United Kingdom due
to a lack of clinical guidelines in this group and could potentially
remain underused even in high-risk group patients. They recom-
mend risk stratiﬁcation to identify individuals who are likely to
beneﬁt from prophylaxis. Up to now no stratiﬁcation method has
proven its superiority or has gained general acceptance. We  would
need to form a uniform national guideline in the management of
such patients.
4.  Conclusion
Routine pharmacological prophylaxis to patients requiring pro-
longed immobilisation in a cast rather than the current practice of
selective use of prophylaxis in high-risk patients is debatable. Fur-
ther high quality research is needed to assess the cost-effectiveness
of the increased resources needed to offer routine prophylaxis
and weigh the risk-beneﬁts to prevent long term morbidity fol-
lowing DVT or fatal complications like PE. The treating surgeon
should have a high index of suspicion and low threshold to prevent
these complications in patients treated with prolonged plaster cast
immobilisation for lower limb injuries.
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